A new class of small molecule inhibitor of BMP signaling.
Growth factor signaling pathways are tightly regulated by phosphorylation and include many important kinase targets of interest for drug discovery. Small molecule inhibitors of the bone morphogenetic protein (BMP) receptor kinase ALK2 (ACVR1) are needed urgently to treat the progressively debilitati...
Main Authors: | Caroline E Sanvitale, Georgina Kerr, Apirat Chaikuad, Marie-Christine Ramel, Agustin H Mohedas, Sabine Reichert, You Wang, James T Triffitt, Gregory D Cuny, Paul B Yu, Caroline S Hill, Alex N Bullock |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3639963?pdf=render |
Similar Items
-
Development of BMP type I receptor kinase inhibitors for the treatment of fibrodysplasia ossificans progressiva and the study of the BMP signaling pathway
by: Mohedas, Agustin Humberto
Published: (2014) -
Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
by: Martin Schröder, et al.
Published: (2021-09-01) -
Comparative studies on the drug target proteins from two human malaria parasites
by: Chaikuad, Apirat
Published: (2009) -
SNW1 is a critical regulator of spatial BMP activity, neural plate border formation, and neural crest specification in vertebrate embryos.
by: Mary Y Wu, et al.
Published: (2011-02-01) -
Role of BMP receptor-associated molecule BRAM1 in BMP signaling
by: Yu-Chen Hsu, et al.
Published: (2004)